JPS61126097A - 抗ヘルペス性を有する新規ヌクレオシド誘導体、該誘導体を含む製薬組成物および有効成分の調製方法 - Google Patents

抗ヘルペス性を有する新規ヌクレオシド誘導体、該誘導体を含む製薬組成物および有効成分の調製方法

Info

Publication number
JPS61126097A
JPS61126097A JP60226674A JP22667485A JPS61126097A JP S61126097 A JPS61126097 A JP S61126097A JP 60226674 A JP60226674 A JP 60226674A JP 22667485 A JP22667485 A JP 22667485A JP S61126097 A JPS61126097 A JP S61126097A
Authority
JP
Japan
Prior art keywords
formula
optionally substituted
compound
compound represented
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP60226674A
Other languages
English (en)
Japanese (ja)
Inventor
アンナ スザボルクス
ラズロ オトボス
アチラ スゼムゾ
ヘルガ トドス
ジヤノス サギ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MAGIYAALE TOUDOMANIYOSU AKADEM
MAGIYAALE TOUDOMANIYOSU AKADEMIA KOZUPONTEI KEMIAI KUTATO INTEZETE
Original Assignee
MAGIYAALE TOUDOMANIYOSU AKADEM
MAGIYAALE TOUDOMANIYOSU AKADEMIA KOZUPONTEI KEMIAI KUTATO INTEZETE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MAGIYAALE TOUDOMANIYOSU AKADEM, MAGIYAALE TOUDOMANIYOSU AKADEMIA KOZUPONTEI KEMIAI KUTATO INTEZETE filed Critical MAGIYAALE TOUDOMANIYOSU AKADEM
Publication of JPS61126097A publication Critical patent/JPS61126097A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
JP60226674A 1984-10-12 1985-10-11 抗ヘルペス性を有する新規ヌクレオシド誘導体、該誘導体を含む製薬組成物および有効成分の調製方法 Pending JPS61126097A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU843821A HU192472B (en) 1984-10-12 1984-10-12 Process for preparing /e/-5-/2-bromo-vinyl/-uracyl derivatives
HU3821/84 1984-10-12

Publications (1)

Publication Number Publication Date
JPS61126097A true JPS61126097A (ja) 1986-06-13

Family

ID=10965655

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60226674A Pending JPS61126097A (ja) 1984-10-12 1985-10-11 抗ヘルペス性を有する新規ヌクレオシド誘導体、該誘導体を含む製薬組成物および有効成分の調製方法

Country Status (18)

Country Link
JP (1) JPS61126097A (da)
KR (1) KR870001935B1 (da)
AT (1) ATA294685A (da)
BE (1) BE903381A (da)
DD (1) DD239595A5 (da)
DE (1) DE3536604A1 (da)
DK (1) DK465585A (da)
ES (1) ES8605819A1 (da)
FI (1) FI853969A7 (da)
FR (1) FR2571726A1 (da)
GB (1) GB2165539A (da)
HU (1) HU192472B (da)
IL (1) IL76661A0 (da)
IT (1) IT1186775B (da)
NL (1) NL8502794A (da)
NO (1) NO854041L (da)
PL (1) PL255741A1 (da)
SE (1) SE8504708L (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8912972D0 (en) * 1989-06-06 1989-07-26 Wellcome Found Therapeutic nucleosides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5136498A (ja) * 1974-09-20 1976-03-27 Tanabe Seiyaku Co 2*2**anhidoroarabinofuranoshirurashirujudotainoseiho
JPS5687599A (en) * 1979-12-19 1981-07-16 Yamasa Shoyu Co Ltd E 55 22halogenovinyl arabinofuranosyluracil and its preparation
NZ199764A (en) * 1981-03-20 1984-08-24 Beecham Group Plc 5-(2-halogenovinyl)-2'-deoxyuridine derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
FI853969L (fi) 1986-04-13
DK465585A (da) 1986-04-13
HU192472B (en) 1987-06-29
FI853969A0 (fi) 1985-10-11
ATA294685A (de) 1987-03-15
PL255741A1 (en) 1986-08-12
NO854041L (no) 1986-04-14
DK465585D0 (da) 1985-10-11
ES547820A0 (es) 1986-04-01
IT1186775B (it) 1987-12-16
BE903381A (fr) 1986-04-07
KR860003270A (ko) 1986-05-21
SE8504708D0 (sv) 1985-10-11
NL8502794A (nl) 1986-05-01
DD239595A5 (de) 1986-10-01
IL76661A0 (en) 1986-02-28
IT8522442A0 (it) 1985-10-11
DE3536604A1 (de) 1986-04-17
FI853969A7 (fi) 1986-04-13
FR2571726A1 (fr) 1986-04-18
HUT38655A (en) 1986-06-30
SE8504708L (sv) 1986-04-13
GB2165539A (en) 1986-04-16
KR870001935B1 (ko) 1987-10-22
GB8525152D0 (en) 1985-11-13
ES8605819A1 (es) 1986-04-01

Similar Documents

Publication Publication Date Title
DK170893B1 (da) Nye 5'-deoxy-5-fluorcytidinderivater, en fremgangsmåde til fremstilling deraf, farmaceutiske midler indeholdende sådanne derivater og anvendelse af derivaterne til fremstilling af et antitumormiddel
DE69721339T2 (de) Monozyklische l-nukleoside, analoga und ihre anwendungen
AU595832B2 (en) Therapeutic nucleosides
KR960007532B1 (ko) 1,3-옥사티오란 뉴클레오시드 동족체
US7019135B2 (en) Anti-viral pyrimidine nucleoside analogues
OA12384A (en) 3'-Prodrugs of 2'-deoxy-beta-l-nucleosides.
JPH01249797A (ja) 2’,3’―ジデオキシ―2’,2’―ジフルオロヌクレオシド類
NO179710B (no) Nye fosfolipidderivater av nukleosider, og legemiddel inneholdende disse
SK119993A3 (en) Antiviral combinations
SK11492002A3 (sk) Nukleozidový analóg s karboxamidínom modifikovanou bázou a jeho použitie
SK281403B6 (sk) N4-alkoxykarbonyl-5'-deoxy-5-fluórcytidínové deriváty, spôsob ich výroby, farmaceutické prostriedky s ich obsahom a ich použitie
MXPA97002932A (en) L-ribofuranosilnucleosi
JPH10507772A (ja) L−リボフラノシルヌクレオシド
JPH0780898B2 (ja) 抗ウイルスヌクレオシド
HU201090B (en) Process for producing dideoxocytidine derivatives and pharmaceutical compositions comprising same as active ingredient
JP2967998B2 (ja) 新規なネプラノシン誘導体類
EP1100786B1 (en) Antiviral pyrimidinedione derivatives and process for the preparation thereof
JPH02160769A (ja) 新規な2′―ハロメチリデン、2′―エテニリデン及び2′―エチニルアデノシン誘導体類
EP0356166B1 (en) Therapeutic nucleosides
PT90475B (pt) Processo para a preparacao de pro-farmacos de 2',3'-didehidro-2',3'-didesoxinucleosidos com accao anti-viral
JPS61126097A (ja) 抗ヘルペス性を有する新規ヌクレオシド誘導体、該誘導体を含む製薬組成物および有効成分の調製方法
WO2006111058A1 (en) N4- (substituted oxycarbonyl)-2’,2’-difluoro-2’-deoxycytidines and uses thereof
EP1968971B1 (en) Dioxolane derivates for the treatment of cancer
US5198539A (en) 5'-esters of 2',3'-dideoxy-3'-fluoro-5-ethynyluridine
US4016262A (en) Therapeutic compositions and methods employing N(6)-disubstituted adenosine compounds